Abstract 152
Background: Natural killer cells (NK cells) are defined as CD56+CD3- cells, displaying a morphology of large granular lymphocytes (LGL cells). NK cells mediate unspecific immunity and are able to kill virus-infected and malignant transformed cells. Cytokine-stimulated NK cells may be useful in clinical trials of immunotherapy. We examined an immunomagnetic enrichment system, which allows a highly selective purification of CD56+ cells.
Material and Measurements: CD56+ cells were isolated by Magnetic Cell Separation (MACS), cord blood (n=12), adult controls (n=10). Cells were stained with T cell specific monoclonal antibodies CD3, CD4, CD8 and with CD56. Flow cytometric analysis was done on a FACScan.
Results: Mononuclear cells displayed a fraction of 9.5% CD56+ cells (range 0.7-21.3%) in neonates and a fraction of 16.6%(range 8.2-33.0%) in adults. Enriched cells (MACS) derived from neonates[adult controls] stained positive for CD56 with 97.2 ± 1.4%(±SD) [96.7 ± 0.7%]. CD56-specific coexpression of T cell markers differed markedly: CD8 was expressed to an extent of 43.6 ± 13.8% [50.8 ± 10.7%]. CD4 was found on CD56+ cells with 3.6± 3.1% [10.4 ± 7.7%]. CD3 displayed significant different values (p<0.02) of 7.2%, range 2.0-17.1%, in neonates, and 35.2%, range 14.3-75.7%, in adult controls.
Conclusions: The method of immunomagnetic isolation represents a powerful tool to enrich selectively CD56+ cell of cord blood and adult controls. Resulting cell populations differed in their coexpression of T cell markers. A remarkable fraction of adult CD56+ cells coexpressed CD3 and should therefore be considered as a T cell subset and not as a NK population. In contrast, the majority (>92%) of neonatal CD56+ cells displayed the NK cell specific CD56+CD3- phenotype.
Supported by fortüne 328, University of Tübingen
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neu, S., Geiselhart, A., Brockmann, Y. et al. Immunomagnetic enrichment of neonatal and adult cytotoxic CD56+ cells. Pediatr Res 44, 444 (1998). https://doi.org/10.1203/00006450-199809000-00185
Issue Date:
DOI: https://doi.org/10.1203/00006450-199809000-00185